James mock joins moderna as chief financial officer

Cambridge, ma / accesswire / august 17, 2022 / moderna, inc., (nasdaq:mrna) a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that james mock has been appointed as moderna's chief financial officer, beginning september 6, 2022. he will serve on moderna's executive committee and report to chief executive officer stÉphane bancel.
MRNA Ratings Summary
MRNA Quant Ranking